In intermediate-risk patients, transcatheter aortic valve replacement (TAVR) had outcomes similar to surgical aortic valve replacement regarding death or disabling stroke.
Does transcatheter aortic-valve replacement (TAVR) reduce death or disabling stroke in intermediate-risk patients compared to surgical aortic-valve replacement?
Intermediate-risk patients requiring aortic-valve replacement
Transcatheter aortic-valve replacement (TAVR)
Surgical aortic-valve replacement
Composite of death or disabling strokecomposite
In intermediate-risk patients, TAVR provides similar outcomes to surgical aortic-valve replacement for the composite of death or disabling stroke.
In intermediate-risk patients, TAVR was similar to surgical aortic-valve replacement with respect to the primary end point of death or disabling stroke. (Funded by Edwards Lifesciences; PARTNER 2 ClinicalTrials.gov number, NCT01314313.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Martin B. Leon
Craig R. Smith
Michael J. Mack
New England Journal of Medicine
Stanford University
University of Pennsylvania
Washington University in St. Louis
Building similarity graph...
Analyzing shared references across papers
Loading...
Leon et al. (Sat,) reported a other. In intermediate-risk patients, transcatheter aortic valve replacement (TAVR) had outcomes similar to surgical aortic valve replacement regarding death or disabling stroke.
www.synapsesocial.com/papers/69615ed33b3c6cd0a4920d12 — DOI: https://doi.org/10.1056/nejmoa1514616
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: